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Abstract: Intracerebral hemorrhages (ICHs) are devastating neurological events frequently resulting in a serious negative prognosis.
The exact physiological and disease processes involved in ICHs are complex, but are thought to involve microRNAs (miRNAs), 22
nucleotide small noncoding RNAs that control a variety of normal physiological and disease processes. In this study, we show that a
miRNA, miR-34a, regulates BDNF in a model of ICH injury. In particular, we assessed the impact of AM34a, an inhibitor of miR-34a, on
the toxicity of thrombin-induced apoptosis and on BDNF-mediated signaling. We investigated the increased expression of miR-34a after
an ICH-induced thrombin toxicity injury using a real-time polymerase chain reaction (RT-PCR) and evaluated miR-34a as a therapeutic
target. Apoptosis was confirmed by 4’,6-diamidino-2-phenylindole using terminal deoxynucleotidyl transferase-mediated digoxigenindUTP-biotin nick-end labeling (TUNEL). The number of apoptotic cells detected by TUNEL after ICH injury was decreased by
AM34a. Additionally, the ICH injury model treated with AM34a had a significantly lower caspase-3 level. We performed western blot
analyses for BDNF, phosphorylated Akt, and phosphorylated ERK. The levels of BDNF were significantly higher in samples treated with
AM34a. Furthermore, the level of phosphorylated Akt and phosphorylated ERK were significantly higher under AM34a. In conclusion,
we demonstrated a distinct miRNA expression pattern after an in vitro ICH injury model, and modulation of this pattern can have
therapeutic potential. miR-34a antagomir reduced cell death and enhanced neurological recovery by activating the BDNF pro-survival
pathway. This suggests that inhibiting miR-34a might be a potential therapeutic target in ICH.
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1. Introduction
Intracerebral hemorrhage (ICH), which accounts for ~15%–
20% of all deaths from stroke, is one of the most devastating
stroke subtypes; it has a grave prognosis and is characterized
by the rupturing of small blood vessels in the brain
parenchyma (Donnan et al., 2008, Qureshi et al., 2009).
Development of novel treatment strategies based on
the distinct pathogenic mechanisms of ICH is warranted
to achieve improved clinical results.
MicroRNA (miRNA) is a short sequence noncoding
RNA with 22 base pairs that regulates gene expression in
the post-transcription step by base-pairing with the target
messenger RNA of the 3′ untranslated region (Kim et al.,
2009), playing significant roles in multiple physiological
and pathological processes (Kloosterman and Plasterk,
2006; Stefani and Slack, 2008). Its expression level is
dynamic in human developmental stages and in diseases,
and several studies have confirmed the therapeutic
potential of modulating miRNA expression (Kim et al.,
2009; Lee et al., 2010; Jimenez-Mateos et al., 2012).
* Correspondence: kjin014@gmail.com

miR-34 was first found in Caenorhabditis elegans in
2001 (Lau et al., 2001). Two subtypes, miR-34a (Agostini
et al., 2011) and miR-34c (Zovoilis et al., 2011), were
subsequently shown to occur in Alzheimer disease (AD).
Studies demonstrated an increase in miR-34a expression
in the brain cortices of AD mouse models (Wang et al.,
2009; Agostini et al., 2011), and a specific interaction
between miR-34a, Tap73, and synaptotagmin-1. In the
brains of patients with AD, the miR-34a, Tap73, and
synaptotagmin-1 circuit is conserved despite aberrant
expression of p73 (Agostini et al., 2011). Tap73 is a p53family member and drives the expression of miR-34a.
Similar studies indicated that miR-34c levels were elevated
in the hippocampus of patients with AD and in diseasemodeling mice, and inhibition of miR-34c improved
memory function (Zovoilis et al., 2011; Hu et al., 2015).
Recently the activity of miR-34 in age-associated changes
and long-term integrity has been positively associated
with ageing and neurodegeneration in Drosophila (Liu et
al., 2012).
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Thus far, the role of miR-34a in ICH has not been
revealed. Whether its inhibition (by countersequenced
miR-34a) would have a neuroprotective effect was thus
studied using an in vitro ICH-induced thrombin toxicity
model.
2. Materials and methods
2.1. A cortical primary culture
Cortical neurons obtained from cerebral cortices of
17-day-old rat embryos were cultured as described
previously (Beaudoin et al., 2012). Then 1 × 106 cells were
seeded per well into a 12-well plate (1 mL/well) coated
with glass coverslips. Cells were grown under standard
conditions at 37 °C and 5% CO2 in Neurobasal medium
with B27 (Invitrogen, Carlsbad, CA, USA) and glutamine
(Invitrogen).
2.2. In vitro thrombin toxicity model and therapeutic
potential study
To simulate neuronal injury, a thrombin in vitro toxicity
model was assembled by using thrombin (Sigma, NY,
USA) to cortical neurons. Thrombin was used at constant
concentration. Then the cell viability was assessed by
the WST-1 cell proliferation assay kit (Roche, Penzberg,
Germany), according to the manufacturer’s instructions.
After using diverse concentrations of thrombin, we
observed that 200 U/mL thrombin administration resulted
in 50% cell death and 500 U/mL thrombin administration
resulted in 90% cell death after 24 h. Thus, 500 U/mL was
chosen as the concentration for thrombin in all further
experiments. The therapeutic potential of AM34a was
studied from the thrombin in vitro injury model. The cells
were transfected by AM34a (50 nM) with Lipofectamine
2000 (Invitrogen). Analyses were performed 48 h after
transfection.
2.3. Quantitative real-time polymerase chain reaction
miRNA was extracted using the mirVana miRNA
isolation kit (Ambion, Austin, TX, USA), following
the manufacturer’s recommended protocol. Realtime polymerase chain reaction (PCR) for miRNA
was performed using commercial kits (GenoSensor
Corporation, Tempe, AZ, USA) and miRNA specific
primer (GenoSensor Corporation). Relative expression
was calculated from the formula: relative expression
= 2–△Ct using the comparative threshold cycle (Ct)
and was normalized with the expression of control
RNU6B (GenoSensor Corporation) from each sample.
The sequences of miRNAs are as follows: miR-34a, 3’UGUUGGUCGAUUCUGUGACGGU-5’. Antagonistic
sequences (AM34a) of single stranded RNAs with
cholesterol residue at the 3’ ending and phosphorothioate
backbone were manufactured to neutralize the targeted
miRNAs (Bioneer, Daejon, Korea).
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2.4. Cell proliferation and MTT assay
Cell survival analysis was conducted according to the
MTT (Cell Titer 96 Aqueous Cell Proliferation Assay
kit; Promega, Madison, WI, USA) assay method. The
absorbance was assessed in a microplate reader at 490 nm,
and the results were shown as a percentage of the control.
2.5. Immunocytochemistry and TUNEL assay
The terminal deoxynucleotidyl transferase mediated
digoxigenin-dUTP-biotin nick-end labeling (TUNEL)
assay using the In Situ Cell Death Detection Kit (Roche,
Penzberg, Germany) was used to show apoptosis by
demonstrating apoptotic bodies in primary cortical
neurons. Apoptotic cells were determined with a model
LSM 510 confocal microscope (Carl Zeiss, Jena, Germany).
Data were expressed as the ratio of apoptotic neurons to
total nuclei. Cell counting was performed by microscope
in triplicate.
2.6. Western blot analysis
Cells were resuspended in a lysis buffer (Cell Signaling
Technology, Beverly, MA, USA) with Protease Inhibitor
Cocktail (complete mini tablet, Roche). The membranes
were blocked by incubation for 1 h at room temperature
and incubated with anti-BDNF (Santa Cruz, CA, USA),
anti-cleaved caspase-3 (Cell Signaling Technology, MA,
USA), anti-phospho-Akt (Cell Signaling Technology),
anti-phospho-ERK (Cell Signaling Technology), and
Actin (Cell Signaling Technology) antibodies at 4 °C
overnight. After three washes, the membranes was further
incubated with horseradish peroxidase-conjugated antisecondary IgG (Invitrogen) antibody and visualized
with Chemiluminescent Substrate (Pierce, IL, USA).
Densitometric quantification of the protein density bands
was performed using the ImageJ software (version 1.29 x,
NIH, Bethesda, MD, USA). Error bars denote the mean
(±SD) of three replicates.
2.7. Statistical analyses
Differences are described as average and standard
deviation. When comparing means between two groups,
Student’s t test was used. P < 0.025 was considered the level
of statistical significance.
3. Results
3.1. MicroRNA 34a expression profile in the ICHinduced thrombin injury model
To simulate injury after ICH, an in vitro thrombin toxicity
model was constructed by applying thrombin to cortical
neurons. The miRNA expression level was then evaluated
in this model. Cortical neuronal cells were cultured in a
neural medium and exposed to 500 U thrombin for 24
h. The level of miR-34a increased significantly 24 h after
thrombin injury (*P < 0.05; Figure 1). We investigated
miR-34a to validate the protective effect of its inhibitory
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Figure 1. MicroRNA 34a expression in the ICH-induced
thrombin injury model. Expression levels of miR-34a in the ICHinduced thrombin injury model were detected using quantitative
polymerase chain reaction assay. Cortical neuronal cells were
cultured in a neural medium and exposed to 500 U of thrombin
for 24 h. The level of miR-34a increased significantly 24 h after
thrombin injury. Values represent the mean ± standard deviation
(SD) of three experiments, with n = 3 dishes/culture for each
concentration. *P < 0.025 compared with nontreated groups.

sequence. The application of AM34a increased cell viability
after the thrombin injury (Figure 2).
3.2. Apoptosis in the ICH-induced thrombin injury
model after AM34a administration
TUNEL assays are a sensitive means of visualizing DNA
damage in single cells; they are also useful for detecting cell
death. Cultured cells were fixed and stained for TUNEL
and 4’, 6-diamidino-2-phenylindole (DAPI) staining.
Confocal microscopy was used to compare the model cells
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Figure 2. Effect of AM34a on cortical neuronal cells exposed to
thrombin. The cells were cultured with and without AM34a and
neurotoxicity was estimated using the MTT assay. The application
of AM34a increased cell viability after the thrombin injury.
Values represent the mean ± standard deviation (SD) of three
experiments, with n = 3 dishes/culture for each concentration
(*P < 0.025).

with and without AM34a. The apoptotic cells measured by
TUNEL after thrombin injury were decreased by AM34a
(*P < 0.025; Figure 3). The AM34a treatment also induced
noticeable functional improvement. A secondary antibody
was used to rule out nonspecific staining (data not shown).
Caspase-3 activation is the key event in apoptotic cell
death. To evaluate the effects of AM34a on neuronal cell
apoptosis, we determined the levels of activated caspase-3
in the thrombin injury model with and without AM34a
treatment by western blot analysis. Cortical neuronal cells
that had been cultured without AM34a showed an increase
in the levels of caspase-3 compared to those cultured with
AM34a (*P < 0.025; Figure 4).
3.3. Effects of AM34a are mediated via activation of the
BDNF-Akt pathway
BDNF is one of the best characterized neurotrophic factors
that are important in neuronal survival, differentiation, and
synaptogenesis. To examine the protective effect of AM34a,
we analyzed BDNF levels. The results from western blot
analysis indicated that BDNF levels increased following
exposure of a thrombin injury model to treatment with
AM34a (*P < 0.025; Figure 5).
Akt phosphorylation inactivates apoptotic factors and
ERK phosphorylation is activated by growth signals. To
examine the underlying mechanisms of these processes,
we analyzed a variety of signaling cascades involved in cell
growth and survival. We performed western blot analyses
for phosphorylated Akt (p-Akt) and phosphorylated ERK
(p-ERK) and found that the levels of both were significantly
higher in the thrombin injury model treated with AM34a
(*P < 0.025; Figures 6 and 7).
4. Discussion
In spite of outstanding progress in ischemic stroke
treatment technology, little progress has been made in the
treatment of ICH in the past 10 years. Several potential
neuroprotective agents have failed to show positive
outcomes, and current effective treatment options for ICH
are still limited to supportive management (Qureshi et
al., 2009; Levi et al., 2010). The present study revealed the
patterns of miRNA expression after ICH induction and
its results indicate that upregulated miRNAs could be a
potential therapeutic target in ICH. When miR-34a was
abrogated by the application of its antagonist, neuronal
survival was increased in the in vitro ICH thrombin
toxicity model, apoptotic cell death was reduced, and
functional improvement was facilitated. miR-34a regulates
BDNF, and AM34a, the antagomir inhibiting miR-34a,
enhances BDNF levels. These results represent the first
evidence that miRNA-dependent dysregulation of BDNF
participates in the pathogenesis of ICH and that AM34a
may be therapeutically effective against this devastating
disorder.
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Figure 3. Detection of apoptosis in cortical neuronal cells by terminal deoxynucleotidyl transferase-mediated digoxigenin-dUTP-biotin
nick-end labeling (TUNEL). The apoptotic cells measured by TUNEL after thrombin injury were decreased by AM34a. Histograms
show the average number of TUNEL-positive cells as percentage for each group. Values represent the mean ± standard deviation (SD)
of three experiments, with n = 3 dishes/culture for each concentration (*P < 0.025 ).
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Figure 4. Anti-apoptotic effects are mediated via activation AM34a. To evaluate the anti-apoptotic effect, we performed western
blot analysis of cleaved caspase-3. The cultured group with AM34a induced a decrease in the level of caspase-3. Values represent
the mean ± standard deviation (SD) of three experiments, with n = 3 dishes/culture for each concentration (*P < 0.025).
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Figure 5. Neuroprotective effects of AM34a are mediated via activation of the BDNF. To examine the protective effect
of AM34a, we analyzed BDNF levels. Thrombin was added to cells in the presence of AM34a, after which toxicity was
estimated by western blotting. Results showed that BDNF levels increased following exposure of a thrombin injury model
to treatment with AM34a. Values represent the mean ± standard deviation (SD) of three experiments, with n = 3 dishes/
culture for each concentration (*P < 0.025).
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Figure 6. AM34a-mediated activation of Akt in cortical neuronal cells. Representative western blots showing protein
levels of phosphorylated Akt and actin in neuronal cells. The western blots presented are representative of three
independent experiments with similar results. Values represent the mean ± standard deviation (SD) of three experiments,
with n = 3 dishes/culture for each concentration (*P < 0.025).
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Figure 7. AM34a-mediated activation of ERK in cortical neuronal cells. Representative western blots showing protein
levels of phosphorylated ERK and actin in neuronal cells. The western blots presented are representative of three
independent experiments with similar results. Values represent the mean ± standard deviation (SD) of three experiments,
with n = 3 dishes/culture for each concentration (*P < 0.025).
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Apoptosis appears to play a key role in the neural
damage caused by stroke (Matsushita et al., 2000;
Qureshi, 2003). The induction of ICH in rats has been
shown to induce neuronal cell death, and apoptosis has
been closely linked to ICHinduced neuronal cell death
(Matsushita et al., 2000). The upregulation of caspase3 is
an important indicator of apoptosis following brain insults
(Benchoua et al., 2004). An increase in the number of
TUNEL and caspase3positive cells in the hippocampus
indicates an increase in apoptotic neuronal cell death in
the hippocampus (Baek et al., 2012). The proapoptotic
molecule causes the death of nerve cells following cerebral
ischemia by the release of cytochrome c and the activation
of caspases (Plesnila et al., 2002). Histological examination
of the ICH-model cells revealed heavy staining on the
TUNEL assay, with the cells demonstrating apoptotic
morphological features. In the present study, we used a
characterized ICH-induced thrombin toxicity model and
we found that AM34a treatment resulted in a decreased
level of cleaved caspase-3, suggesting that AM34a exerts
an anti-apoptotic effect.
BDNF is a small dimeric protein that modulates
neuronal cell growth and survival and has been implicated in
learning and memory processes. Accordingly, dysfunction
in BDNF is accompanied by cognitive deficits (GomezPinilla and Vaynman, 2005). Specifically, BDNF enhances
hippocampaldependent memory and a form of synaptic
plasticity (Minichiello, 2009), BDNF concentrations are
high in the hippocampus, and its expression is selectively
increased during learning and memory tasks (Zimmerberg
et al., 2009). In the present study, the level of BDNF was
decreased in the ICH-induced thrombin toxicity model.
The reduced BDNF level is involved in the impairment
induced by ICH-induced thrombin toxicity. By contrast,
AM34a treatment led to increased levels of BDNF in the
model. The results from the present study indicate that
AM34a increased BDNF and ameliorated some of the
negative effects of the toxicity in the model.

The PI3K/Akt signaling pathway mediates mitogendependent growth and survival, and inhibition of this
pathway results in apoptosis (Shin et al., 2012). Akt activity
can be modulated by phosphorylation of either Thr308 or
Ser47e (Koide et al., 2011). Phosphorylation of Akt itself
inactivates pro-apoptotic factors and inhibits apoptosis
(Lubinus et al., 1994; Li et al., 2013). Akt and ERK are known
to inhibit apoptosis by inhibiting caspase activation. In the
current study, we used a characterized cortical neuronal
cell ICH thrombin toxicity model. Akt expression in this
model was influenced by AM34a modulation, and the cell
survival pathway activated by AM34a treatment is thus a
reasonable potential therapeutic mechanism of AM34a.
In addition, phosphorylation and activation of Akt may
underlie the observed protective effect of BDNF. The
neuroprotective effect of AM34a is probably mediated by
BDNF pathway up-reregulation with decreased apoptotic
cell death. In particular, the anti-apoptotic effect may result
from the AM34a-mediated increase in the expression of
BDNF via activation of the Akt and ERK pathways. Based
on these results, AM34a may be a good candidate for
exerting a neuroprotective effect and improving neuronal
recovery following apoptosis.
Thrombin was applied on the cortical neuronal cells to
mimic an in vitro ICH-induced toxicity condition, and it
is obvious that more extensive mechanisms are related to
posthemorrhagic neuronal damage (Qureshi et al., 2009).
In the present study, we evaluated the protective effect
of miR-34a as derived from this in vitro model. Further
studies regarding manipulation of in vivo ICH models are
necessary to confirm the benefit of the miRNA modulation
strategy. In conclusion, we demonstrated a distinct
miRNA expression pattern after an in vitro ICH injury
and revealed that its modulation can have therapeutic
potential. miR-34a antagomir reduced cell death and
enhanced neurological recovery by activating the BDNF
pro-survival pathway. This suggests that inhibiting miR34a might be of potential therapeutic use in ICH.
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